Analysis of SonoThera Appoints Adam J. Shaywitz, M.D., Ph.D., as Chief Medical Officer - aVenture Research
SonoThera
SonoThera Appoints Adam J. Shaywitz, M.D., Ph.D., as Chief Medical Officer
SAN FRANCISCO–(BUSINESS WIRE)–SonoThera, a biotechnology company developing next-generation genetic medicines to address the root causes of disease, today announced the appointment of Adam J. Shaywitz, M.D., Ph.D., as Chief Medical Officer. Dr. Shaywitz brings two decades of biopharmaceutical industry experience spanning early- and late-stage drug development, with particular expertise in genetic medicine, rare diseases, and […]
An analysis reads this article and its sources, then explains what happened, who is involved, and what it means, quoting a source for each claim. Once written, every reader sees it here.
Analysis requires a paid plan or prepaid credits and uses your company research allowance.